secwatch / observer
8-K filed May 1, 2026, 7:59 PM ET ticker RREV CIK 0002123969
other material confidence high sentiment neutral materiality 0.85

RRE Ventures Acquisition Corp. prices and closes $250M IPO; units begin trading on Nasdaq

RRE Ventures Acquisition Corp.

item 1.01item 3.02item 5.02item 5.03item 8.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-26-201578
form_type
8-K
ticker
RREV
cik
0002123969
company_name
RRE Ventures Acquisition Corp.
filed_at
2026-05-01T23:59:59+00:00
discovered_at
2026-05-14T18:02:33.509350+00:00
generated_at
2026-05-15T00:24:52.982522+00:00
sec_items
["1.01", "3.02", "5.02", "5.03", "8.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.85
calibrated_materiality_score
0.85
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-26-201578
json_url
https://secwatch.observer/filing/0001193125-26-201578.json
markdown_url
https://secwatch.observer/filing/0001193125-26-201578.md
text_url
https://secwatch.observer/filing/0001193125-26-201578.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/d77496d8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dan Galpern

Director
RREV · RRE Ventures Acquisition Corp.
Effective
2026-04-29
Filed
May 1, 2026, 7:59 PM ET
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed

Brian Daly

Director
RREV · RRE Ventures Acquisition Corp.
Effective
2026-04-29
Filed
May 1, 2026, 7:59 PM ET
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed

Bruce Bernstein

Director
RREV · RRE Ventures Acquisition Corp.
Effective
2026-04-29
Filed
May 1, 2026, 7:59 PM ET
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed

James Gertler

Director
RREV · RRE Ventures Acquisition Corp.
Effective
2026-04-29
Filed
May 1, 2026, 7:59 PM ET
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed

Robert S. Mancini

Director
RREV · RRE Ventures Acquisition Corp.
Effective
2026-04-29
Filed
May 1, 2026, 7:59 PM ET
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed

Kendrick Meek

Director
RREV · RRE Ventures Acquisition Corp.
Effective
2026-04-29
Filed
May 1, 2026, 7:59 PM ET
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Source-grounded claims

4ee5b6fab4

Dan Galpern was appointed as Director at RRE Ventures Acquisition Corp..

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

6ab0f4729d

Brian Daly was appointed as Director at RRE Ventures Acquisition Corp..

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

9fad66bec1

Bruce Bernstein was appointed as Director at RRE Ventures Acquisition Corp..

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

c139add5fb

James Gertler was appointed as Director at RRE Ventures Acquisition Corp..

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

cc52cb425e

Robert S. Mancini was appointed as Director at RRE Ventures Acquisition Corp..

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

f442518f35

Kendrick Meek was appointed as Director at RRE Ventures Acquisition Corp..

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

a244c9f5fb6c9a1a997fe739ce0c4cbabad86951

RRE Ventures Acquisition Corp.: Amended and restated memorandum and articles of association filed in connection with IPO (effective 2026-04-29).

On April 28, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 29, 2026.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

5f53886fa5786596c048504893554fc75432329d

RRE Ventures Acquisition Corp. entered into Underwriting Agreement with Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, as representative of the several underwriters (effective 2026-04-29).

On April 29, 2026, RRE Ventures Acquisition Corp. (the “ Company ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (“ Cohen ”), as representative of the several underwriters (the “ Underwriters ”), relating to the initial public offering (“ IPO ”) of the Company’s units (the “ Public Units ”).

SEC 8-K Item 1.01/1.02 confidence 0.99 SEC evidence

Comparable filings

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: executive_change, governance_change, material_agreement same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Comparable filing

John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

Filing page SEC filing

FDXF

FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed

FedEx Freight Holding Company, Inc. June 1, 2026, 6:46 AM ET other_material Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01

same fact type: executive_change same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Comparable filing

each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board

Filing page SEC filing

FXAC

FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross

FortuneX Acquisition Corp May 29, 2026, 5:32 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 9.01

same fact type: executive_change same SEC item: 1.01, 3.02, 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Comparable filing

Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.

Filing page SEC filing

ELOX

Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors

Eloxx Pharmaceuticals, Inc. June 1, 2026, 7:00 AM ET other_material Items 3.02, 3.03, 5.03, 5.02, 9.01

same fact type: executive_change same SEC item: 3.02, 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Comparable filing

the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board

Filing page SEC filing

CWBHF

Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment

Charlotte's Web Holdings, Inc. June 1, 2026, 5:13 PM ET other_material Items 5.02, 5.07, 8.01

same fact type: executive_change same SEC item: 5.02, 8.01 same event type: other_material similar materiality

This filing

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Comparable filing

Effective May 28, 2026 (the “Effective Date”), the board of directors of Charlotte’s Web Holdings, Inc. (the “Company”), appoint James Jeffery Raborn to the Company’s board of directors

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Comparable filing

On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 8.01, 9.01 same event type: other_material

This filing

On April 28, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 29, 2026.

Comparable filing

On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.

Filing page SEC filing

CRMT

America's Car-Mart forms special committee for strategic alternatives; appoints new independent director

AMERICAS CARMART INC May 29, 2026, 5:30 PM ET other_material Items 1.01, 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 1.01, 5.02, 8.01, 9.01 same event type: other_material

This filing

James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Comparable filing

On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-26-201578
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.